MX2022002275A - Tropoelastina para uso en el tratamiento de cicatrices de acne. - Google Patents
Tropoelastina para uso en el tratamiento de cicatrices de acne.Info
- Publication number
- MX2022002275A MX2022002275A MX2022002275A MX2022002275A MX2022002275A MX 2022002275 A MX2022002275 A MX 2022002275A MX 2022002275 A MX2022002275 A MX 2022002275A MX 2022002275 A MX2022002275 A MX 2022002275A MX 2022002275 A MX2022002275 A MX 2022002275A
- Authority
- MX
- Mexico
- Prior art keywords
- acne scar
- treatment
- tropoelastin
- acne
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente descripción proporciona métodos para el tratamiento de una cicatriz de acné para mejorar el color y/o apariencia, y/o reducir la profundidad, área afectada, y/o volumen de la cicatriz de acné. Estos métodos pueden comprender administrar una composición que comprende tropoelastina a un área de la piel que tiene la cicatriz de acné y alterar opcionalmente las fibras fibróticas debajo de la cicatriz de acné y administrar la composición debajo de la cicatriz de acné.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962891232P | 2019-08-23 | 2019-08-23 | |
PCT/EP2020/073516 WO2021037733A1 (en) | 2019-08-23 | 2020-08-21 | Tropoelastin for use in treatment of acne scarring |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022002275A true MX2022002275A (es) | 2022-06-02 |
Family
ID=72292495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022002275A MX2022002275A (es) | 2019-08-23 | 2020-08-21 | Tropoelastina para uso en el tratamiento de cicatrices de acne. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220288171A1 (es) |
EP (1) | EP4017519A1 (es) |
JP (2) | JP7491999B2 (es) |
CN (1) | CN114938631A (es) |
AU (1) | AU2020338139A1 (es) |
BR (1) | BR112022003367A2 (es) |
CA (1) | CA3152006A1 (es) |
MX (1) | MX2022002275A (es) |
WO (1) | WO2021037733A1 (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994014958A1 (en) | 1992-12-22 | 1994-07-07 | The University Of Sydney | Synthetic polynucleotides |
AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
AUPP472398A0 (en) | 1998-07-17 | 1998-08-13 | University Of Sydney, The | Protease susceptibility II |
BRPI1009422B1 (pt) | 2009-03-10 | 2019-10-01 | Elastagen Pty Ltd | Biomateriais injetáveis |
JP6231004B2 (ja) * | 2011-09-30 | 2017-11-15 | エラスタジェン・プロプライエタリー・リミテッドElastagen Pty Ltd | 弾性線維のin vivo合成 |
AU2015239688B2 (en) * | 2014-04-01 | 2020-06-25 | Galderma Research & Development | Combination of adapalene and benzoyl peroxide for treating acne scars |
-
2020
- 2020-08-21 MX MX2022002275A patent/MX2022002275A/es unknown
- 2020-08-21 AU AU2020338139A patent/AU2020338139A1/en active Pending
- 2020-08-21 US US17/637,799 patent/US20220288171A1/en active Pending
- 2020-08-21 EP EP20764591.2A patent/EP4017519A1/en active Pending
- 2020-08-21 WO PCT/EP2020/073516 patent/WO2021037733A1/en unknown
- 2020-08-21 BR BR112022003367A patent/BR112022003367A2/pt unknown
- 2020-08-21 CN CN202080070348.1A patent/CN114938631A/zh active Pending
- 2020-08-21 CA CA3152006A patent/CA3152006A1/en active Pending
- 2020-08-21 JP JP2022512322A patent/JP7491999B2/ja active Active
-
2024
- 2024-05-16 JP JP2024080196A patent/JP2024112890A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021037733A1 (en) | 2021-03-04 |
AU2020338139A1 (en) | 2022-04-07 |
CN114938631A (zh) | 2022-08-23 |
CA3152006A1 (en) | 2021-03-04 |
JP2024112890A (ja) | 2024-08-21 |
JP2022545278A (ja) | 2022-10-26 |
EP4017519A1 (en) | 2022-06-29 |
JP7491999B2 (ja) | 2024-05-28 |
BR112022003367A2 (pt) | 2022-05-17 |
US20220288171A1 (en) | 2022-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023001527A (es) | Compuestos con actividad inductora de ferroptosis y metodos de uso de estos. | |
MX2023008453A (es) | Metodos de tratamiento para el abuso de sustancias. | |
WO2006127467A3 (en) | Subdermal cryogenic remodeling | |
WO2014138582A3 (en) | Rapid pulse electrohydraulic shockwave generator | |
MX2019004549A (es) | Combinaciones que comprenden un inhibidor ssao/vap-1 y un inhibidor sglt2 y usos de los mismos. | |
MX2021010173A (es) | Compuestos con actividad inductora de ferroptosis y métodos de uso. | |
MX2023007212A (es) | Formulaciones de pulverizacion de epinefrina. | |
WO2011063237A3 (en) | Jagged-binding agents and uses thereof | |
WO2018143552A3 (ko) | 탈모방지 또는 발모촉진용 주사용 조성물 | |
MX2020001727A (es) | Terapia de combinacion. | |
ZA202211665B (en) | Ammonia oxidizing bacteria for treatment of acne | |
MX2020005785A (es) | Formulaciones inyectables de toxina botulínica y métodos de uso de las mismas que tienen una alta tasa de respuesta y una larga duración del efecto. | |
MX2019013862A (es) | Terapia de combinacion. | |
PH12019500758A1 (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
MX2021003006A (es) | Bacterioterapia contra proprionibacterium acnes para el tratamiento de acne. | |
MX2024005453A (es) | Composiciones y tratamientos con nirogacestat. | |
MX344281B (es) | Uso de paulownin y/o extractos de madera de paulownia para preparar composiciones topicas para el tratamiento de la celulitis. | |
GB2525517A (en) | Topical preparation for pain relief | |
MX345695B (es) | Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel. | |
WO2008066775A3 (en) | Compositions and methods to reduce fat and retract skin | |
MX2023010512A (es) | Agentes de union multiespecificos contra cd40 y cd137 en terapia. | |
MX2020013103A (es) | Metodos de uso de cd24 para la prevencion y tratamiento de recaida de leucemia. | |
EP2786765A3 (en) | Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor | |
AU2020327022A8 (en) | Method of treating cancer | |
PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer |